Solmi Marco, Veronese Nicola, Favaro Angela, Santonastaso Paolo, Manzato Enzo, Sergi Giuseppe, Correll Christoph U
Department of Neurosciences, University of Padova, Padova, Italy.
Department of Medicine-DIMED, Geriatrics Section, University of Padova, Padova, Italy.
Psychoneuroendocrinology. 2015 Jan;51:237-52. doi: 10.1016/j.psyneuen.2014.09.031. Epub 2014 Oct 8.
Although inflammation is increasingly implicated in psychiatric disorders, less is known about its role in anorexia nervosa (AN), an illness with low body mass index (BMI).
We performed a systematic PubMed literature search until 12/31/2013 and meta-analyzed cross-sectional and longitudinal studies comparing circulating pro- and anti-inflammatory cytokines between patients with anorexia nervosa (AN) and healthy controls (HCs) (1) before and (2) after weight gain, and (3) within AN patients before and after weight gain. Standardized mean differences (SMDs)± 95% confidence intervals (CIs) for results from ≥ 2 studies were calculated.
Of 999 initial hits, 22 studies with 924 participants (AN=512, HCs=412) were eligible. Compared to HCs, tumor necrosis factor (TNF)-alpha (SMD=0.35, 95%CI=0.09-0.61, p=0.008), interleukin (IL)1-beta (SMD=0.51, 95%CI=0.18-0.84, p=0.003), IL-6 (SMD=0.43, 95%CI=0.11-0.76, p=0.009), and TNF-receptor-II (SMD=0.42, 95%CI:0.07-0.78, p=0.02) were significantly elevated in AN, while C-reactive protein (SMD=-0.53, 95%CI=-.77, -0.28, p<0.0001) and IL-6 receptor (SMD=-0.85, 95%CI=-1.33, -0.36, p=0.0006) were significantly decreased. No differences were found for TNF-receptor I and TGF-β. Across a subset of eight longitudinal studies (AN=152, HCs=129), significant weight gain (baseline BMI=15.4 ± 1.5, endpoint BMI=18.2 ± 1.6, p<0.0001) was not associated with significant changes in TNF-α, IL-6 and IL1-β. However, after weight gain, IL-6 was not different anymore compared to HCs (SMD=0.06, 95%CI=-0.32, 0.45, p=0.75). In meta-regression, shorter illness duration (p=0.0008), but not younger age (p=0.71) significantly moderated greater IL-6 levels.
Despite abnormally low BMI, AN seems to be associated with increased inflammatory cytokines. Whether specific elevated cytokines represent trait or state markers of AN, and whether they could be treatment targets requires further study.
尽管炎症与精神疾病的关联日益受到关注,但对于其在神经性厌食症(AN)中的作用却知之甚少,神经性厌食症患者的体重指数(BMI)较低。
我们在PubMed数据库中进行了系统的文献检索,截止到2013年12月31日,并对比较神经性厌食症(AN)患者与健康对照(HCs)之间循环促炎和抗炎细胞因子的横断面和纵向研究进行了荟萃分析,比较内容包括:(1)体重增加前;(2)体重增加后;(3)AN患者体重增加前后。计算≥2项研究结果的标准化平均差(SMD)±95%置信区间(CI)。
在999条初始检索结果中,22项研究符合要求,共924名参与者(AN = 512名,HCs = 412名)。与HCs相比,AN患者的肿瘤坏死因子(TNF)-α(SMD = 0.35,95%CI = 0.09 - 0.61,p = 0.008)、白细胞介素(IL)1-β(SMD = 0.51,95%CI = 0.18 - 0.84,p = 0.003)、IL-6(SMD = 0.43,95%CI = 0.11 - 0.76,p = 0.009)和TNF受体-II(SMD = 0.42,95%CI:0.07 - 0.78,p = 0.02)显著升高,而C反应蛋白(SMD = -0.53,95%CI = -0.77,-0.28,p < 0.0001)和IL-6受体(SMD = -0.85,95%CI = -1.33,-0.36,p = 0.0006)显著降低。TNF受体I和转化生长因子-β无差异。在八项纵向研究的子集中(AN = 152名,HCs = 129名),体重显著增加(基线BMI = 15.4 ± 1.5,终点BMI = 18.2 ± 1.6,p < 0.0001)与TNF-α、IL-6和IL1-β的显著变化无关。然而,体重增加后,与HCs相比IL-6不再有差异(SMD = 0.06,95%CI = -0.32,0.45,p = 0.75)。在荟萃回归分析中,病程较短(p = 0.0008)而非年龄较小(p = 0.71)显著调节了更高的IL-6水平。
尽管BMI异常低,但AN似乎与炎症细胞因子增加有关。特定升高的细胞因子是AN的特质还是状态标志物,以及它们是否可作为治疗靶点,都需要进一步研究。